excited to start on editorial board j urology and fun to see it in print ! I hope to live up to the legacy of Dr Grayhack, my first urology mentor. I'm always open to hear new ideas and research to champion !
Today at Book Q&A with Deborah Kalb, Diana Farid talks about THE LIGHT OF HOME, finding a sense of home and belonging, and how art is "a way of moving through our hardest moments, surviving, breathing, and eventually meeting love again." bit.ly/3B2vC3N
#immigrationstories #picturebook #art
sharing my first conference post on this platform. with Dr Shuch presenting on #kidneycancer molecular imaging at #suo2024
trying to highlight that avoiding definitive treatment for low risk cancer is only part of the challenge of overtreatment - we also need to consider the host - and avoid futile toxicity in men unlikely to benefit from definitive treatment due to their multi morbidity...
true. we dont report pt specific outcomes:
guidelines require life expectancy estimates. We show (on population level) using a validated tool to estimate LE, that pts with limited life expectancy are increasingly being treated. (e.g. intermediate risk #prostatecancer and life expectancy < 5 years)
Works as well as for intermediate / high risk disease too... The biopsy confirmed that you have cancer, but we can still prioritize other aspects of your health... or lets monitor this cancer because initial treatment may worsen your quality of life...
Thanks for sharing ! Hoping we can raise awareness about the importance of understanding life expectancy in personalized / precision cancer care
now online from Tim Daskivich et al - from JAMA Internal Medicine: Overtreatment of #ProstateCancer in men with limited longevity is actually increasing in the active surveillance era
@StanfordUrology
@StanfordCancer
@CedarsSinai
jamanetwork.com/journals/jam...